Challenges and Perspectives on the Adoption of Cystatin C testing in China: A laboratory technician's perspective

Xiaerbanu Nizhamuding,Yang Liu,Jie Zeng,Haijian Zhao,Tianjiao Zhang,Chuanbao Zhang
DOI: https://doi.org/10.1016/j.clinbiochem.2024.110839
IF: 3.625
2024-11-04
Clinical Biochemistry
Abstract:Cystatin C (CysC) belongs to the cysteine protease inhibitor superfamily and is produced by all nucleated cells in the body in very stable amounts independent of age, sex, diet, and muscle mass. CysC is considered an ideal biomarker for assessing glomerular filtration rate (GFR) compared to traditional biomarkers for assessing GFR, such as creatinine. However, CysC is not sufficiently utilized for GFR assessment by clinicians, probably for various reasons such as insufficient understanding among clinicians or a lack of standardized quantitative methods. This review discusses and analyzes the aforementioned issues from the perspective of laboratory technicians.
medical laboratory technology
What problem does this paper attempt to address?